Drug Markets/Bimatoprost

Bimatoprost

24 NDCs across 8 manufacturers|19 Generic,5 Brand

Bimatoprost is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Mar 16, 2001, and the first generic was approved Dec 1, 2014. FDA's Orange Book lists 3 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $656 million on Bimatoprost across 1.5 million claims for 357,000 beneficiaries.

Bimatoprost is available as 24 NDCs from 8 manufacturers (19 generic, 5 brand), with NADAC prices from $4.23 to $103.10 per MLthe most expensive product costs about 24× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

24

19G / 5B

Manufacturers

8

competing in market

Price Spread

$4.23 – $103.10

per ML

7d Activity

1590 flat

avg +1.0% WoW · of 24 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

24 NDCs total, 24 shown

Drug Price 7d Change
LUMIGAN 0.01% EYE DROPS
$103.0951
per ML
-0.05%
LUMIGAN 0.01% EYE DROPS
$103.0828
per ML
-0.11%
LUMIGAN 0.01% EYE DROPS
$103.0104
per ML
-0.05%
LATISSE 0.03% EYELASH SOLUTION
$40.9950
per ML
+0.03%
LATISSE 0.03% EYELASH SOLUTION
$31.4808
per ML
-0.17%
BIMATOPROST 0.03% EYELASH SOLN
$27.1437
per ML
+0.87%
BIMATOPROST 0.03% EYELASH SOLN
$27.1437
per ML
+0.87%
BIMATOPROST 0.03% EYELASH SOLN
$21.5809
per ML
-0.76%
BIMATOPROST 0.03% EYELASH SOLN
$21.5809
per ML
-0.76%
BIMATOPROST 0.03% EYE DROPS
$8.8723
per ML
+8.19%
BIMATOPROST 0.03% EYE DROPS
$8.8723
per ML
+8.19%
BIMATOPROST 0.03% EYE DROPS
$8.8723
per ML
+8.19%
BIMATOPROST 0.03% EYE DROPS
$8.8723
per ML
+8.19%
BIMATOPROST 0.03% EYE DROPS
$8.8723
per ML
+8.19%
BIMATOPROST 0.03% EYE DROPS
$8.8723
per ML
+8.19%
BIMATOPROST 0.03% EYE DROPS
$7.3396
per ML
+3.76%
BIMATOPROST 0.03% EYE DROPS
$7.3396
per ML
+3.76%
BIMATOPROST 0.03% EYE DROPS
$7.3396
per ML
+3.76%
BIMATOPROST 0.03% EYE DROPS
$7.3396
per ML
+3.76%
BIMATOPROST 0.03% EYE DROPS
$7.3396
per ML
+3.76%
BIMATOPROST 0.03% EYE DROPS
$7.3396
per ML
+3.76%
BIMATOPROST 0.03% EYE DROPS
$4.2350
per ML
-15.80%
BIMATOPROST 0.03% EYE DROPS
$4.2350
per ML
-15.80%
BIMATOPROST 0.03% EYE DROPS
$4.2350
per ML
-15.80%

Frequently Asked Questions

What is Bimatoprost used to treat?

Bimatoprost is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.

When did Bimatoprost become available as a generic?

FDA approved the first generic Bimatoprost (ANDA) on Dec 1, 2014. The Orange Book currently lists 3 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Bimatoprost?

In 2024, Medicare Part D spent $656 million on Bimatoprost across 1.5 million claims for 357,000 beneficiaries.

How many Bimatoprost products are on the market?

The Bimatoprost drug market contains 24 NDCs from 8 manufacturers — 19 generic and 5 brand products.

What is the price range for Bimatoprost?

NADAC reference prices for Bimatoprost range from $4.2350 to $103.0951 per ML — the most expensive product costs about 24× the cheapest.

Is generic Bimatoprost cheaper than brand?

The average generic NADAC for Bimatoprost is $10.9172 per ML, versus $76.3328 for brand-labeled products — brand versions average about 7.0× the generic price.

Which manufacturers make Bimatoprost?

8 manufacturers list Bimatoprost in NADAC. Ranked by number of NDCs, the largest are Allergan, Inc. (5), Alembic Pharmaceuticals Inc. (4), Micro Labs Limited (3), Aurobindo Pharma Limited (3), Somerset Therapeutics, LLC (3).

How has the price of Bimatoprost changed recently?

Over the past 7 days, 15 Bimatoprost NDCs rose and 9 fell, with a market-wide average change of +1.0%.